Indeed, a minor proportion of LUADs without NE morphology present a certain degree of NE features at diagnosis and may be enriched for EGFR mutations and ALK translocations,46 and similarly, a small percentage of treatment-naive advanced prostate adenocarcinomas exhibit NE differentiation47 (Fig. 3). This evidence concerns the gene EGFR and prostate adenocarcinoma.